Clinical Trials Browser

Cone Dystrophy 3 × Carboplatin × Clear all

NCT01916109 2016-02-12

Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Phase 2 Terminated

4 enrolled 6 charts

Cone Dystrophy 3, Urinary Bladder Neoplasms